BEVERLY HILLS, CA - (NewMediaWire) - June 27, 2023 - Announced today: Nitric Oxide Innovations (NOi) drug company founder and CEO, Nathan S. Bryan Ph.D proudly announces that world renowned board certified neurologist, six-time New York Times bestselling Author David Perlmutter, M.D. has joined (NOi) to lead the N101 Alzheimer’s and neurodegenerative drug program. Dr. Bryan, (NOi) and Pneuma Nitric Oxide, LLC are represented by Alan Morell and Creative Management Partners (CMP), Beverly Hills, CA.
Said Dr. Nathan Bryan Ph D., “I am extremely proud and honored to announce that Dr. David Perlmutter, board certified neurologist and one of the first to recognize Alzheimer’s’ disease as a metabolic disease, as our Director of Neuroscience Research. As we enter into clinical trials on Alzheimer’s disease with our nitric oxide drug, there is no one more qualified to guide our development program on neurodegenerative disease. We realize nitric oxide is a game changer in therapeutics. It improves circulation, reduces inflammation, oxidative stress and immune dysfunction but also improves insulin signaling and cellular metabolism, the underlying causes of neurodegenerative disease, including Alzheimer’s disease. With Dr. Permutter’s guidance, we hope to expedite our Alzheimer’s drug study and finally get a safe and effective treatment approved for this horrible degenerative disease. Everything we know about the cause of Alzheimer’s disease appears to be corrected by nitric oxide.”
made many seminal discoveries in the field. His many seminal discoveries have resulted in dozens of issued US and International patents and the product technology resulting from his discoveries and inventions has improved patient care worldwide. Most recently, Dr. Bryan serves as Founder and CEO of Nitric Oxide Innovations (NOi), a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of nitric oxide based therapies for ischemic heart disease, ischemic, non-obstructive coronary disease, Alzheimer’s disease and topical wound care for pressure ulcers. Dr. Bryan is an international leader in molecular medicine and nitric oxide biochemistry.